Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP)

Main Content

Permission is required for each single use of the MDS Clinical Outcome Assessments. 

Request permission »   View more assessments »

The Self-Administered Screening Questionnaire for Parkinson's Disease-Associated Psychosis (SASPAP) is a 4-question screening assessment for psychosis in PD, which can be self-administered or administered at patient intake.  Development included input for patients, patient advocates, neurologists, and psychiatrists, following a modified Delphi plan, which included several rounds of revisions and Beta testing.  The questionnaire shows very good sensitivity and specificity when compared to blinded interviews and administration of the Parkinson’s disease Psychosis Scale by PD experts. It is used only to assess the presence of psychosis and is not meant to be a severity scale.

Authors: Vindhya Koneru, Alberto J Espay, Allan J Cole, Daniel Weintraub, Kathleen Crist, Maria B Pascual, William G Ondo

Original PublicationView the Scale (PDF)  Permission required for use

  • Acronym: SASPAP
  • Year Published: 2023
  • Scale Last Updated: No updates since publication
  • Assessment Type: PROs
  • Estimated Time to Complete: 2-4 minutes

To request permission to use this Rating Scale, please fill out a Permission Request Form.

Request Permission »
 

Browse all 30+ MDS assessments

View all »

Become a Member

 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice